Proposed Data Collections Submitted for Public Comment and Recommendations, 6722-6724 [2015-02328]
Download as PDF
<![CDATA[
6722
Federal Register / Vol. 80, No. 25 / Friday, February 6, 2015 / Notices
I. Background
Vaccination is one of the most
important public health achievements of
the 20th century. Vaccines save lives
and improve the quality of life by
reducing the transmission of infectious
diseases. However, the benefits of
vaccination are not realized equally
across the U.S. population. Adult
vaccination rates remain low in the
United States and far below Healthy
People 2020 targets. In an average year,
95 percent of the approximately 20,000
to 50,000 Americans who die as a result
of vaccine-preventable disease are
adults, depending on the severity of
annual influenza outbreaks. Substantial
racial and ethnic disparities also exist.
The National Vaccine Plan (NVP),
released in 2010, provides a guiding
vision for vaccination in the United
States for the decade 2010–2020. While
the NVP serves as a roadmap for
protecting all U.S. residents from
vaccine-preventable diseases,
historically low vaccination rates in the
adult population and unique attributes
of the adult vaccination delivery system
highlight the need for focused attention
on adult vaccination.
The NAIP is a five year national plan
with an emphasis on coordination and
prioritization of what federal and nonfederal partners can accomplish
together. Given this time frame, the
NAIP will be informed by emerging
science and changing circumstances.
The NAIP also aims to leverage the
unique opportunity presented by the
passage and ongoing implementation of
the Affordable Care Act.
Through their analysis and
discussion, NVPO identified four major
goals:
Goal 1: Strengthen the adult
immunization infrastructure
Goal 2: Improve access to adult vaccines
Goal 3: Increase community demand for
adult immunizations
Goal 4: Foster innovation in adult
vaccine development and vaccination
related technologies
Within each goal, the NAIP details
measurable objectives and subobjectives.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
II. Request for Comment
NVPO requests input on the draft
report and draft recommendations. In
addition to general comments on the
draft NAIP, NVPO is seeking input on
efforts or barriers to adult
immunizations not represented in the
report where HHS efforts could advance
adult immunization efforts. Please limit
your comments to six (6) pages.
VerDate Sep<11>2014
18:52 Feb 05, 2015
Jkt 235001
III. Potential Responders
HHS invites input from a broad range
of stakeholders including individuals
and organizations that have interests in
adult immunization efforts and the role
of HHS in advancing those efforts.
Examples of potential responders
include, but are not limited to, the
following:
—general public;
—advocacy groups, non-profit
organizations, and public interest
organizations;
—academics, professional societies, and
healthcare organizations;
—public health officials and
immunization program managers;
—provider groups including all
physician and non-physician
providers that administer
immunization services to adults,
including pharmacists; and
—representatives from the private
sector.
When responding, please self-identify
with any of the above or other categories
(include all that apply) and your name.
Anonymous submissions will not be
considered. Written submissions should
not exceed six (6) pages. Please do not
send proprietary, commercial, financial,
business, confidential, trade secret, or
personal information.
Dated: January 27, 2015.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2015–02481 Filed 2–5–15; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–15–0964]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. To request more
information on the below proposed
project or to obtain a copy of the
information collection plan and
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Interventions to Reduce Shoulder
MSDs in Overhead Assembly (OMB No.
0920–0964, expires 4/30/2015)—
Extension—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
and prevention. Under Public Law 91–
596, sections 20 and 22 (Section 20–22,
Occupational Safety and Health Act of
1970), NIOSH has the responsibility to
conduct research to advance the health
and safety of workers. In this capacity,
NIOSH proposes a three year extension
E:\FR\FM\06FEN1.SGM
06FEN1
6723
Federal Register / Vol. 80, No. 25 / Friday, February 6, 2015 / Notices
for a study to assess the effectiveness
and cost-benefit of occupational safety
and health interventions to prevent
musculoskeletal disorders (MSDs)
among workers in the Manufacturing
(MNF) sector.
An extension is requested for this ICR
because only one quarter of the
necessary sample size was enrolled
during the previous cycle. The eligible
employee population will be expanded
to include other Departments at the
facility to achieve the necessary sample
size. It is believed that the targeted
number of interventions, which was not
achieved in the previous year, can be
achieved by expanding to additional
Departments.
Musculoskeletal disorders (MSDs)
represent a major proportion of injury/
illness incidence and cost in the U.S.
Manufacturing (MNF) sector. In 2008,
29% of non-fatal injuries and illnesses
involving days away from work (DAW)
in the MNF sector involved MSDs and
the MNF sector had some of the highest
rates of MSD DAW cases. The rate for
the motor vehicle manufacturing subsector (NAICS 3361) was among the
highest of MNF sub sectors, with MSD
DAW rates that were higher than the
general manufacturing MSD DAW rates
from 2003–2007.
In automotive manufacturing,
overhead conveyance of the vehicle
chassis requires assembly line
employees to use tools in working
postures with the arms elevated. These
postures are believed to be associated
with symptoms of upper limb
discomfort, fatigue, and impingement
syndromes (Fischer et al., 2007).
Overhead working posture, independent
of the force or load exerted with the
hands, may play a role in the
development in these conditions.
Recent studies suggest a more
significant role of localized shoulder
muscle fatigue in contributing to these
disorders. Fatigue of the shoulder
muscles may result in changes in
normal shoulder kinematics (motion)
that affect risk for shoulder
impingement disorders (Ebaugh et. al.,
2006; Chopp et al., 2010).
manufacturing facility in Georgetown,
Kentucky.
The prospective intervention
evaluation study will be conducted
using a group-randomized controlled
trial multi-time series design. Four
groups of 25–30 employees will be
established to test the two intervention
treatment conditions (tool support,
exercise program), a combined
intervention treatment condition, and a
control condition. The four groups will
be comprised of employees working on
two vehicle assembly lines in different
parts of the facility, on two work shifts
(first and second shift).
Individual randomization to treatment
condition is not feasible, so a grouprandomization (by work unit) will be
used to assign the four groups to
treatment and control conditions.
Observations will be made over the
10-month study period and
questionnaires will include the
Shoulder Rating Questionnaire (SRQ),
Disabilities of the Arm, Shoulder and
Hand (DASH) questionnaire, a
Standardized Nordic Questionnaire for
body part discomfort, and a Work
Organization Questionnaire. In addition
to the monthly questionnaires, a
shoulder-specific functional capacity
evaluation test battery will be
administered pre- and post-intervention,
to confirm the efficacy of the targeted
exercise program in improving shoulder
capacity.
In summary, this study will evaluate
the effectiveness of two interventions to
reduce musculoskeletal symptoms and
pain in the shoulder associated with
repetitive overhead work in the
manufacturing industry. The evidencebased prevention practices that may
result from this associated research
project will be disseminated to the
greatest audience possible.
NIOSH expects to complete data
collection in 2015–2016 and there is no
cost to employee respondents, as they
will participate in this study during
their normal working hours at their
regular wage.
The U.S. Manufacturing sector has
faced a number of challenges including
an overall decline in jobs, an aging
workforce, and changes in
organizational management systems.
Studies have indicated that the average
age of industrial workers is increasing
and that older workers may differ from
younger workers in work capacity,
injury risk, severity of injuries, and
speed of recovery (Kenny et al., 2008;
Gall et al., 2004; Restrepo et al., 2006).
As the average age of the industrial
population increases and newer systems
of work organization (such as lean
manufacturing) are changing the nature
of labor-intensive work, prevention of
MSDs will be more critical to protecting
older workers and maintaining
productivity.
This study will evaluate the efficacy
of two intervention strategies for
reducing musculoskeletal symptoms
and pain in the shoulder attributable to
overhead assembly work in automotive
manufacturing. These interventions are,
(1) an articulating spring-tensioned tool
support device that unloads from the
worker the weight of the tool that would
otherwise be manually supported, and,
(2) a targeted exercise program intended
to increase individual employees’
strength and endurance in the shoulder
and upper arm stabilizing muscle group.
As a primary prevention strategy, the
tool support engineering control
approach is preferred; however, a costefficient opportunity exists to
concurrently evaluate the efficacy of a
preventive exercise program
intervention. Both of these intervention
approaches have been used in the
Manufacturing sector, and preliminary
evidence suggests that both approaches
may have merit. However, high quality
evidence demonstrating their
effectiveness, by way of controlled
trials, is lacking.
This project will be conducted as a
partnership between NIOSH and Toyota
Motors Engineering & Manufacturing
North America, Inc. (TEMA), with the
intervention evaluation study taking
place at the Toyota Motor
Manufacturing Kentucky, Inc. (TMMK)
asabaliauskas on DSK5VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Employees ........
PAR–Q (Physical Activity Readiness) ..............................
Shoulder Rating Questionnaire (SRQ) .............................
Disabilities of the Arm Shoulder and Hand (DASH) ........
Standardized Nordic Questionnaire for Musculoskeletal
Symptoms.
Work Organization Questionnaire ....................................
VerDate Sep<11>2014
18:52 Feb 05, 2015
Jkt 235001
PO 00000
Number of
respondents
Frm 00043
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
125
125
125
125
1
10
10
10
2/60
4/60
6/60
4/60
4
83
125
83
125
3
26/60
163
E:\FR\FM\06FEN1.SGM
06FEN1
6724
Federal Register / Vol. 80, No. 25 / Friday, February 6, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
...........................................................................................
........................
........................
........................
Type of
respondents
Total ...........
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–02328 Filed 2–5–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–R–245]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by March 9, 2015.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:52 Feb 05, 2015
Jkt 235001
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 or Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare and
Medicaid Programs OASIS Collection
Requirements as Part of the CoPs for
HHAs and Supporting Regulations; Use:
The Outcome and Assessment
Information Set (OASIS) data set is
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Total burden
(in hours)
458
currently mandated for use by Home
Health Agencies (HHAs) as a condition
of participation (CoP) in the Medicare
program. Since 1999, the Medicare CoPs
have mandated that HHAs use the
OASIS data set when evaluating adult
non-maternity patients receiving skilled
services. The OASIS is a core standard
assessment data set that agencies
integrate into their own patient-specific,
comprehensive assessment to identify
each patient’s need for home care that
meets the patient’s medical, nursing,
rehabilitative, social, and discharge
planning needs.
The Office of Management and Budget
(OMB) approved the OASIS–C1
information collection request on
February 6, 2014. We originally planned
to use OASIS–C1 to coincide with the
original implementation of ICD–10 on
October 1, 2014. However, on April 1,
2014, the Protecting Access to Medicare
Act of 2014 (PAMA) (Pub. L. 113–93)
was enacted. This legislation prohibits
CMS from adopting ICD–10 coding prior
to October 1, 2015. Because OASIS–C1
is based on ICD–10 coding, it is not
possible to implement OASIS–C1 prior
to October 1, 2015, when ICD–10 is
implemented. The passage of the PAMA
Act left us with the dilemma of how to
collect OASIS data in the interim, until
ICD–10 is implemented.
The OASIS–C1/ICD–9 version is an
interim version of the OASIS–C1 data
item set that was created in response to
the legislatively mandated ICD–10
delay. There are five items in OASIS–C1
that require ICD–10 codes. In the
OASIS–C1/ICD–9 version, these items
have been replaced with the
corresponding items from OASIS–C that
use ICD–9 coding. The OASIS–C1/ICD–
9 version also incorporates updated
clinical concepts, modified item
wording and response categories and
improved item clarity. In addition, the
OASIS–C1/ICD–9 version includes a
significant decrease in provider burden
that was accomplished by the deletion
of a number of non-essential data items
from the OASIS–C data item set. Form
Number: CMS–R–245 (OMB control
number: 0938–0760); Frequency:
Occasionally; Affected Public: Private
sector—business or other for-profit and
not-for-profit institutions; Number of
Respondents: 12,014; Total Annual
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 80, Number 25 (Friday, February 6, 2015)]
[Notices]
[Pages 6722-6724]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-02328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-0964]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden and maximize the utility
of government information, invites the general public and other Federal
agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. To request more information on the below
proposed project or to obtain a copy of the information collection plan
and instruments, call 404-639-7570 or send comments to Leroy A.
Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an
email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
Interventions to Reduce Shoulder MSDs in Overhead Assembly (OMB No.
0920-0964, expires 4/30/2015)--Extension--National Institute for
Occupational Safety and Health (NIOSH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. Under Public Law 91-596, sections 20
and 22 (Section 20-22, Occupational Safety and Health Act of 1970),
NIOSH has the responsibility to conduct research to advance the health
and safety of workers. In this capacity, NIOSH proposes a three year
extension
[[Page 6723]]
for a study to assess the effectiveness and cost-benefit of
occupational safety and health interventions to prevent musculoskeletal
disorders (MSDs) among workers in the Manufacturing (MNF) sector.
An extension is requested for this ICR because only one quarter of
the necessary sample size was enrolled during the previous cycle. The
eligible employee population will be expanded to include other
Departments at the facility to achieve the necessary sample size. It is
believed that the targeted number of interventions, which was not
achieved in the previous year, can be achieved by expanding to
additional Departments.
Musculoskeletal disorders (MSDs) represent a major proportion of
injury/illness incidence and cost in the U.S. Manufacturing (MNF)
sector. In 2008, 29% of non-fatal injuries and illnesses involving days
away from work (DAW) in the MNF sector involved MSDs and the MNF sector
had some of the highest rates of MSD DAW cases. The rate for the motor
vehicle manufacturing sub-sector (NAICS 3361) was among the highest of
MNF sub sectors, with MSD DAW rates that were higher than the general
manufacturing MSD DAW rates from 2003-2007.
In automotive manufacturing, overhead conveyance of the vehicle
chassis requires assembly line employees to use tools in working
postures with the arms elevated. These postures are believed to be
associated with symptoms of upper limb discomfort, fatigue, and
impingement syndromes (Fischer et al., 2007). Overhead working posture,
independent of the force or load exerted with the hands, may play a
role in the development in these conditions.
Recent studies suggest a more significant role of localized
shoulder muscle fatigue in contributing to these disorders. Fatigue of
the shoulder muscles may result in changes in normal shoulder
kinematics (motion) that affect risk for shoulder impingement disorders
(Ebaugh et. al., 2006; Chopp et al., 2010).
The U.S. Manufacturing sector has faced a number of challenges
including an overall decline in jobs, an aging workforce, and changes
in organizational management systems. Studies have indicated that the
average age of industrial workers is increasing and that older workers
may differ from younger workers in work capacity, injury risk, severity
of injuries, and speed of recovery (Kenny et al., 2008; Gall et al.,
2004; Restrepo et al., 2006). As the average age of the industrial
population increases and newer systems of work organization (such as
lean manufacturing) are changing the nature of labor-intensive work,
prevention of MSDs will be more critical to protecting older workers
and maintaining productivity.
This study will evaluate the efficacy of two intervention
strategies for reducing musculoskeletal symptoms and pain in the
shoulder attributable to overhead assembly work in automotive
manufacturing. These interventions are, (1) an articulating spring-
tensioned tool support device that unloads from the worker the weight
of the tool that would otherwise be manually supported, and, (2) a
targeted exercise program intended to increase individual employees'
strength and endurance in the shoulder and upper arm stabilizing muscle
group. As a primary prevention strategy, the tool support engineering
control approach is preferred; however, a cost-efficient opportunity
exists to concurrently evaluate the efficacy of a preventive exercise
program intervention. Both of these intervention approaches have been
used in the Manufacturing sector, and preliminary evidence suggests
that both approaches may have merit. However, high quality evidence
demonstrating their effectiveness, by way of controlled trials, is
lacking.
This project will be conducted as a partnership between NIOSH and
Toyota Motors Engineering & Manufacturing North America, Inc. (TEMA),
with the intervention evaluation study taking place at the Toyota Motor
Manufacturing Kentucky, Inc. (TMMK) manufacturing facility in
Georgetown, Kentucky.
The prospective intervention evaluation study will be conducted
using a group-randomized controlled trial multi-time series design.
Four groups of 25-30 employees will be established to test the two
intervention treatment conditions (tool support, exercise program), a
combined intervention treatment condition, and a control condition. The
four groups will be comprised of employees working on two vehicle
assembly lines in different parts of the facility, on two work shifts
(first and second shift).
Individual randomization to treatment condition is not feasible, so
a group-randomization (by work unit) will be used to assign the four
groups to treatment and control conditions.
Observations will be made over the 10-month study period and
questionnaires will include the Shoulder Rating Questionnaire (SRQ),
Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, a
Standardized Nordic Questionnaire for body part discomfort, and a Work
Organization Questionnaire. In addition to the monthly questionnaires,
a shoulder-specific functional capacity evaluation test battery will be
administered pre- and post-intervention, to confirm the efficacy of the
targeted exercise program in improving shoulder capacity.
In summary, this study will evaluate the effectiveness of two
interventions to reduce musculoskeletal symptoms and pain in the
shoulder associated with repetitive overhead work in the manufacturing
industry. The evidence-based prevention practices that may result from
this associated research project will be disseminated to the greatest
audience possible.
NIOSH expects to complete data collection in 2015-2016 and there is
no cost to employee respondents, as they will participate in this study
during their normal working hours at their regular wage.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Employees................. PAR-Q (Physical 125 1 2/60 4
Activity Readiness).
Shoulder Rating 125 10 4/60 83
Questionnaire (SRQ).
Disabilities of the 125 10 6/60 125
Arm Shoulder and
Hand (DASH).
Standardized Nordic 125 10 4/60 83
Questionnaire for
Musculoskeletal
Symptoms.
Work Organization 125 3 26/60 163
Questionnaire.
-------------------------------------------------------------------------------------
[[Page 6724]]
Total................. .................... .............. .............. .............. 458
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-02328 Filed 2-5-15; 8:45 am]
BILLING CODE 4163-18-P
